New breast cancer drug ‘unaffordable’ for NHS

Charities disappointed at NICE’s draft decision not to recommend KadcylaRelated items from OnMedicaMortality higher if using paroxetine and tamoxifenBreast cancer rate falls with decline in HRT useData don’t support HRT for chronic disease preventionBenefit of Herceptin in more breast cancer casesDrugs regulators “put profits before patients”
Source: OnMedica Latest News - Category: UK Health Source Type: news